indazoles has been researched along with Hemangiopericytoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, M; Kamada, R; Nakanishi, K; Nishikawa, T; Oka, T; Shioyama, W; Yagi, T; Yasui, T | 1 |
| Alentorn, A; Apra, C; Kalamarides, M; Mokhtari, K; Sanson, M | 1 |
2 other study(ies) available for indazoles and Hemangiopericytoma
| Article | Year |
|---|---|
Symptomatic Sinus Bradycardia in a Patient with Solitary Fibrous Tumor/Hemangiopericytoma Treated with Pazopanib.
Topics: Bradycardia; Hemangiopericytoma; Humans; Indazoles; Male; Neoplasm Recurrence, Local; Pyrimidines; Solitary Fibrous Tumors; Sulfonamides | 2021 |
Pazopanib efficacy in recurrent central nervous system hemangiopericytomas.
Topics: Adult; Angiogenesis Inhibitors; Central Nervous System Neoplasms; Female; Hemangiopericytoma; Humans; Indazoles; Male; Middle Aged; Neoplasm Recurrence, Local; Pyrimidines; Solitary Fibrous Tumors; Sulfonamides; Treatment Outcome | 2018 |